entertainment -WSS

entertainment

author：Wikipedia 2025-09-27 12:13:15 - browse：91

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Why Charlie Gard's case is so disturbing to Americans

WSS

FTX founder Sam Bankman

Biden praises World Series champion Astros for impact off the field during White House celebration

Biden praises World Series champion Astros for impact off the field during White House celebration

Bristol 'take

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

FDA authorizes Novavax’s updated Covid

focus

entertainment

focus

In age of alternative facts, a scholarly course on calling out crap

Was Amgen transparent enough on FDA's concern on cancer drug?

Continuity nursing helped my family in our darkest PICU moments

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Wildfire smoke exposes gaps in outdoor worker protections

Physician executives need more than on

How to save PrEP access — and even expand it

CDC launches VaccineFinder tool to locate Covid

BioMarin wins approval for gene therapy to treat hemophilia A

Lessons Learned: This is why you network to find that industry job you want

Wikipedia

FDA rejects Alnylam's heart disease treatment over insufficient data

Senate panel eyes new effort on drug shortages

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

A virus, fished out of a lake, may have saved a man’s life

Chan Zuckerberg Biohub Chicago to focus on inflammation

CDC launches VaccineFinder tool to locate Covid

knowledge

focus

explore

explore